Type 2 Diabetes Mellitus and the Elderly: An Update on Drugs Used to Treat Glycaemia | Bentham Science
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Review Article

Type 2 Diabetes Mellitus and the Elderly: An Update on Drugs Used to Treat Glycaemia

Author(s): Asimina Mitrakou, Niki Katsiki and Nebojsa M. Lalic

Volume 15, Issue 1, 2017

Page: [19 - 29] Pages: 11

DOI: 10.2174/1570161114666160822154816

Price: $65

Open Access Journals Promotions 2
Abstract

Type 2 Diabetes Mellitus (T2DM) and its complications are more prevalent in the elderly. As the general population worldwide is ageing, effective and safe treatment of older T2DM patients is becoming more important in clinical practice. Elderly T2DM patients should be carefully evaluated for functional, mental, geriatric and medical disorders before the initiation of antidiabetic drug therapy and regularly monitored thereafter. Treatment strategy and goals should be individualized based on patient comorbidities and drug pharmacokinetic and pharmacodynamic properties. This narrative review discusses the use of antidiabetic drugs in the elderly T2DM population.

Keywords: Elderly, type 2 diabetes mellitus, antidiabetic drugs, kidney dysfunction, diabetic complications.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy